Seattle, WA, United States of America

Anne-Reńee Van Der Vuurst De Vries


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2007-2011

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Anne-Reńee Van Der Vuurst De Vries: Pioneering Immune Regulation

Introduction

Anne-Reńee Van Der Vuurst De Vries, based in Seattle, WA, is a notable inventor known for his contributions to the field of immunology. With a focus on developing innovative solutions for regulating immune responses, he has secured two patents that underscore his expertise and dedication to advancing medical science.

Latest Patents

His latest patents include groundbreaking work centered around antibodies that bind human OX2 receptors. These patents detail isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions derived from them. The isolated receptors have significant potential in regulating immune responses and can also be utilized in screening for inhibitors or agonists, showcasing their versatility in therapeutic applications.

Career Highlights

Anne-Reńee Van Der Vuurst De Vries currently works at Immunex Corporation, a leader in biopharmaceutical innovations. His role there allows him to collaborate with top professionals in the industry, driving forward groundbreaking research that has the potential to impact various areas of healthcare.

Collaborations

He collaborates closely with Laurent J. Galibert, a valued coworker who contributes to their shared objectives. Together, they work on pioneering projects that aim to enhance our understanding of immune system regulation and develop new therapeutic avenues.

Conclusion

With his impressive background and impactful patents, Anne-Reńee Van Der Vuurst De Vries continues to be a significant figure in the field of immunology. His work not only advances scientific understanding but also opens up new possibilities in the treatment of immune-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…